Please use this identifier to cite or link to this item: doi:10.22028/D291-43315
Title: Rapid analysis of amatoxins in human urine by means of affinity column chromatography and liquid chromatography-high-resolution tandem mass spectrometry
Author(s): Vollmer, Aline C.
Fecher-Trost, Claudia
Bever, Candace S.
Tam, Christina C.
Wagmann, Lea
Meyer, Markus R.
Language: English
Title: Scientific Reports
Volume: 14
Issue: 1
Publisher/Platform: Springer Nature
Year of Publication: 2024
Free key words: Method development
Amatoxins
Monoclonal antibody
Magnetic beads
Afnity column chromatography
Liquid chromatography-high-resolution mass spectrometry
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Analysis of amatoxins is of great importance as these cyclic peptides contribute to a high number of fatalities each year. Development of analytical approaches needs to focus on rapid, sensitive, and reliable methods. By establishing an afnity column chromatography-based assay using the monoclonal amanitin antibody AMA9G3 and liquid chromatography (LC) coupled to high-resolution mass spectrometry (HRMS) for the trace detection of α-, β-, and γ-amanitin in human urine samples to confrm ingestion, we report the frst approach that extents the current status of amatoxin analysis. The presented procedure allows detection of amatoxins in human urine down to 1 ng/mL. The method was successfully validated qualitatively for α- and γ-amanitin according to international recommendations. A proof of concept was performed by analyzing 37 urine samples after suspected amatoxin consumption submitted for regular clinical toxicological analysis. Using this antibody-based enrichment strategy, acute amatoxin intoxications can be determined within 90 min and due to the high sensitivity and selectivity, a comparable approach using target specifc antibodies may also be used for other toxicological relevant peptides.
DOI of the first publication: 10.1038/s41598-024-72463-3
URL of the first publication: https://www.nature.com/articles/s41598-024-72463-3
Link to this record: urn:nbn:de:bsz:291--ds-433152
hdl:20.500.11880/38838
http://dx.doi.org/10.22028/D291-43315
ISSN: 2045-2322
Date of registration: 29-Oct-2024
Description of the related object: Supplementary Information
Related object: https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-024-72463-3/MediaObjects/41598_2024_72463_MOESM1_ESM.pdf
Faculty: M - Medizinische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
Professorship: M - Prof. Dr. Veit Flockerzi
M - Prof. Dr. Markus Meyer
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
s41598-024-72463-3.pdf1,02 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons